Bionet Strategic Asset Allocation Index
Bionet strategic asset allocation index. Bionet (1784) has a Strategic Asset Allocation Index of 37.2% as of June 2023. Strategic assets (PP&E of NT$502.40 Million plus long-term investments of NT$-) total NT$502.40 Million, measured against net assets of NT$1.35 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Bionet (1784) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Bionet (2017–2021)
Strategic asset allocation index of Bionet from 2017 to 2021. This chart shows how Bionet's Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of June 2023, the index stands at 37.2%, representing strategic assets of NT$502.40 Million against net assets of NT$1.35 Billion TWD.
Bionet Strategic Asset Allocation Index by Year (2017–2021)
Bionet strategic asset allocation index by year from 2017 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Bionet from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 1784 stock market capitalisation.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 39.2% | NT$515.20 Million | NT$515.20 Million | NT$- | NT$1.32 Billion | ▼ -1.2 pp |
| 2020 | 40.4% | NT$520.69 Million | NT$520.69 Million | NT$- | NT$1.29 Billion | ▲ +0.2 pp |
| 2019 | 40.2% | NT$525.30 Million | NT$525.30 Million | NT$- | NT$1.31 Billion | ▲ +1.2 pp |
| 2018 | 39.0% | NT$522.95 Million | NT$522.95 Million | NT$- | NT$1.34 Billion | ▲ +0.1 pp |
| 2017 | 39.0% | NT$534.50 Million | NT$534.50 Million | NT$- | NT$1.37 Billion | — |